Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06796348

Radiofrequency Ablation Versus Hemithyroidectomy of Small Thyroid Cancers

Multi-center, 1:1 Randomized, Stratified, Parallel-group, Non-inferiority Clinical Trial of Small Thyroid Cancers Treated with Hemithyroidectomy or Radiofrequency Ablation.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
88 (estimated)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

This is a multicenter randomized controlled trial including patients with small (\<2 cm) suspected or confirmed thyroid cancers. Patients are included after informed consent and randomized to one of two treatments. One treatment is a standard henithyroidectomy and the second treatment is radiofrequency ablation (RFA) of the specific tumor. The investigators will evaluate initial outcome of the allocated treatment, thyroid hormonal function, oncologic safety, quality of life, and treatment costs in a follow-up period of five years after treatment. The overall aim of the study is to improve patient's health by reducing the number of operations on small thyroid cancers. In patients with these small tumors, the long-term adverse outcome may be higher than possible benefits from the operation. For participants undergoing surgical treatment with HT, the investigators will measure final histology and both beneficial and adverse outcome from the operation. For participants undergoing RFA, the investigators expect to reduce the need for thyroid hormonal substitutions, reduce the surgical adverse outcomes, reduce treatment costs and increase QoL without a reduction in oncologic safety and outcome.

Conditions

Interventions

TypeNameDescription
PROCEDURERadiofrequency ablation aloneRFA of a cancer in the thyroid gland.
PROCEDURESurgeryHemithyroidectomy of the thyroid lobe with cancer

Timeline

Start date
2025-03-01
Primary completion
2028-02-28
Completion
2028-04-01
First posted
2025-01-28
Last updated
2025-01-28

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06796348. Inclusion in this directory is not an endorsement.